16-31076358-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_014699.4(ZNF646):c.34G>A(p.Asp12Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,460,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014699.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF646 | NM_014699.4 | c.34G>A | p.Asp12Asn | missense_variant | 2/3 | ENST00000300850.5 | NP_055514.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF646 | ENST00000300850.5 | c.34G>A | p.Asp12Asn | missense_variant | 2/3 | 1 | NM_014699.4 | ENSP00000300850.5 | ||
ZNF646 | ENST00000394979.2 | c.34G>A | p.Asp12Asn | missense_variant | 1/1 | 6 | ENSP00000378429.2 | |||
ZNF646 | ENST00000428260.1 | c.34G>A | p.Asp12Asn | missense_variant | 2/2 | 3 | ENSP00000391271.1 | |||
ZNF646 | ENST00000564189.1 | c.34G>A | p.Asp12Asn | missense_variant | 2/2 | 2 | ENSP00000456651.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250642Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135474
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460832Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 726616
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.34G>A (p.D12N) alteration is located in exon 2 (coding exon 1) of the ZNF646 gene. This alteration results from a G to A substitution at nucleotide position 34, causing the aspartic acid (D) at amino acid position 12 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at